Roche Nabs $1B Majority In Cancer Research Co.
Swiss biotech giant Roche Holding said Monday that it's buying a majority stake in Foundation Medicine, a molecular information company focused on cancer research, for just over $1 billion....To view the full article, register now.
Already a subscriber? Click here to view full article